Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
IRBESARTAN
Aprovel
Hypertension
L_9917NO PROBLEMNCT00265967Summary
IRBESARTAN
Aprovel
Hypertension, Arterial
PM_C_0024ARCHIPELAGOEudraCT: 2005-002161-36Summary Results
IRBESARTAN
Aprovel
Hypertension
PM_L_0255I SELECTNCT00362037Summary
IRBESARTAN
Aprovel
Hypertension
PM_L_0256I PREVENTNCT00362258Summary
IRBESARTAN
Aprovel
Hypertension
R_8791AMISHNCT00264212Summary
IRBESARTAN
Aprovel
Hypertension
R_9511RIATNCT00258921Summary
ISATUXIMAB
NA
Lymphoma or Leukemia
ACT14596ISLAYEudraCT: 2016-002739-14Tabulated Results
ISATUXIMAB
Not marketed
Prostate Cancer or Non-small Cell Lung Cancer
ACT15319NANCT03367819Tabulated Results
ISATUXIMAB
Sarclisa
Lymphoma
ACT15320NAEudraCT Number: 2018-002442-37Summary
ISATUXIMAB
Sarclisa
Neoplasm
ACT15377NANCT03637764Tabulated Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted